Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Sell
12,458
-91
-0.7% -$8.31K 0.17% 83
2026
Q1
$1.29M Sell
12,549
-447
-3% -$50.5K 0.2% 80
2025
Q4
$1.63M Hold
12,996
0.26% 78
2025
Q3
$1.74M Sell
12,996
-227
-2% -$29.8K 0.29% 75
2025
Q2
$1.8M Hold
13,223
0.32% 71
2025
Q1
$1.75M Sell
13,223
-45
-0.3% -$5.73K 0.32% 70
2024
Q4
$1.5M Sell
13,268
-146
-1% -$16.9K 0.28% 73
2024
Q3
$1.53M Sell
13,414
-245
-2% -$26.9K 0.28% 71
2024
Q2
$1.42M Sell
13,659
-218
-2% -$23.1K 0.29% 71
2024
Q1
$1.58M Sell
13,877
-326
-2% -$37.4K 0.31% 74
2023
Q4
$1.56M Sell
14,203
-2,838
-17% -$284K 0.34% 76
2023
Q3
$1.65M Buy
17,041
+689
+4% +$72.4K 0.38% 71
2023
Q2
$1.78M Sell
16,352
-567
-3% -$60.4K 0.39% 68
2023
Q1
$1.71M Sell
16,919
-1,828
-10% -$193K 0.37% 70
2022
Q4
$2.06M Buy
18,747
+1,521
+9% +$157K 0.44% 63
2022
Q3
$1.67M Buy
17,226
+55
+0.3% +$5.86K 0.41% 60
2022
Q2
$1.87M Buy
+17,171
New +$1.95M 0.43% 62

Other funds holding ABT

Advocate Group's ABT Position: Q2 2026 in Review

Advocate Group reduced its Abbott (ABT) stake by 0.73% in Q2 2026, selling an estimated $8.31K and leaving 12,458 shares worth $1.13M. The position accounts for 0.17% of the portfolio, ranked #83.

Advocate Group first reported a position in ABT in Q2 2022 and has held it in 17 quarters since. The position peaked at $2.06M in Q4 2022. 1,385 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Advocate Group held 12,458 shares of Abbott worth $1.13M as of Q2 2026.
  • Advocate Group sold 91 Abbott shares in Q2 2026, an estimated $8.31K.
  • Abbott made up 0.17% of Advocate Group's portfolio in Q2 2026, its #83 holding.
  • Advocate Group first reported a position in Abbott in Q2 2022 and has held it in 17 quarters since.
  • Advocate Group's Abbott position peaked at $2.06M in Q4 2022.
  • 1,385 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Advocate Group's 13F filing for Q2 2026, filed 17 Jul 2026.